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Abstract 
The cell cycle is an important biological process in which a set of events occurs in a 
sequential manner progressing to the cell division. Cell cycle is regulated by periodic 
fluctuations in the expression levels of several genes referred to as cell cycle regulated genes.  
In this study, we apply machine learning techniques to prioritize a list of candidate genes with 
respect to being involved in the cell cycle regulation process. We focus on the data obtained 
from different expression experiments on which partial least squares regression (PLS) models 
have been previously developed to identify genes with cell cycle dependent expression 
profiles. The different expression experiments used different synchronization methods to halt 
the cell cultures, so that each experiment started to measure gene expression values at 
different cell cycle phases after synchronization. We are mainly interested in genes having 
cyclic expression profile which is consistent with respect to cell cycle phases within all 
experiments. Our goal is therefore to develop a method that can identify genes that have 
consistent cyclic expression profiles across multiple synchronization experiments. 
We solve the cell cycle related gene prioritization problem through a novelty detection 
approach using one-class support vector machine. The candidate genes are ranked according 
to their similarity to the genes with known cell cycle function. After checking the function of 
the top ranked genes, it is found that most of them are involved in biological processes related 
to the cell cycle, which is a good indication that our approach is able to prioritize genes with 
cell cycle function. 
 
Keywords: Cell cycle, Partial least squares (PLS), Gene prioritization, one-class support 
vector machine. 
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1. Introduction 
This introductory chapter presents the biological context and several basic background topics 
for understanding the development of this thesis. Section 1.1 introduces the concept of the cell 
cycle. Section 1.2 focuses on the cell cycle control system and regulation of the cell cycle. 
Section 1.3 is dedicated to cell synchronization and presents a summary of several 
synchronization methods. Section 1.4 is a brief overview of the basic concepts involved in 
microarray experiments. Section 1.5 outlines the approach of partial least squares and 
describes how it is being applied to identify genes with cyclic expression profiles. Section 1.6 
presents the theory of support vector machine and its mathematical foundations. Section 1.7 
gives a brief summary of multiple kernel learning approach. Section 1.8 introduces three 
different methods used for integration of datasets. Section 1.9 describes the gene prioritization 
problem that is the focus of this thesis.  
1.1. Cell cycle 
The cell cycle is a complex biological process in which a set of cellular stages occurs in a 
sequential manner progressing to the cell division. The cell cycle is a period of time in which 
a cell is formed from its dividing parent cell until its own division into two cells. Cell division 
is the main component of the cell cycle (Campbell et al. 2008). 
In prokaryotic (cells without a nucleus), the cell cycle is done through a process called binary 
fission. In eukaryotes (cells with a nucleus), the cell cycle is divided in two major phases: a 
growing phase (inter phase) and mitotic phase (M phase). The interphase, in which the cell 
grows and its chromosomes are copied to be prepared for the cell division, often consists of 
90 percent of the cell cycle.  
The interphase proceeds in three sub phases: the first gap (G1 phase), the synthesis phase (S 
phase), and the second gap (G2 phase). The cell continues growing during all three sub 
phases. G1 is the starting phase of the cell cycle and it is where a cell grows and increases in 
size. DNA replication happens during S phase. Each chromosome is single in the start of S 
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phase. After DNA replication, at the end of S phase, the chromosomes are double. In G2 the 
cell grows more to complete preparation for the cell division.  
The M phase is the shortest part during the cell cycle and consists of only about 10 percent of 
the cell cycle. M phase is divided into two processes: mitosis and cytokinesis. The division of 
the nucleus happens in mitosis and is followed by cytokinesis, the division of the cytoplasm. 
Growth of the cell stops at the M phase and cellular energy is used for the division of the cell 
into two daughter cells. The cell cycle may then be repeated by the daughter cells through G1 
phase (Alberts et al. 2008; Campbell et al. 2008). 
Cells that have temporarily left the cell cycle and stopped dividing are in a state of quiescence 
called G0 phase. In the human body, most of the cells are actually in the G0 phase. For 
instance, mature, fully formed nerve cells and muscle cells do not divide at all while skin cells 
divide frequently. 
 
 
Figure 1: Phases of the eukaryotic cell cycle  
(Adopted from Campbell 2008) 
 
1.2. Regulation of the cell cycle 
The sequential events of the cell cycle are controlled by a cell cycle control system. The cell 
cycle control system contains a set of molecules in the cell that operates cyclically to trigger 
and coordinate what happens in the cell cycle. The cell cycle is regulated at certain check 
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points in all of its phases. Checkpoints are used by the cell to control the progress of the cell 
cycle and ensure that the received amount of genetic information in the resulting daughter 
cells is in the appropriate amount. If any damages are distinguished by checkpoints, they 
respond to it by halting the cell cycle to provide time for repair. 
Three main cell cycle checkpoints are: the G1 checkpoint also known as the restriction point, 
the G2 checkpoint, and the M checkpoint also known as the spindle checkpoint. The G1 
checkpoint is placed at the end of the cell cycle's G1 phase, before entry into the S phase. It 
makes sure that the cell is large enough to enter the S phase. If a go ahead signal is received 
by a cell at the G1 checkpoint, the cell proceeds to the S phase. In the case of not receiving a 
go ahead signal, the cell leaves the cell cycle and switches into the quiescent G0 phase. The 
G2 checkpoint is placed at the end of the G2 phase. It makes the decision that DNA 
replication in S phase has been completed, replication errors have been fixed, and the cell is 
ready for mitosis. The M checkpoint is placed at the end of the M phase. It ensures whether 
all the chromosomes are correctly attached to the spindle microtubules (Elledge 1996). 
 In addition, to avoid abnormal cell growth that could cause tumor development, the cell cycle 
control system regulates when and how much the cells of a given tissue proliferate. Tumors 
are caused by abnormal proliferation resulting from alterations in cell cycle regulatory 
system. In the cases where one or more of such controls are disrupted, abnormal excessive 
growth will happen leading to defects and diseases (Whitfield et al. 2006). 
The transitions between the cell cycle stages are regulated via a complex network of protein 
interactions. Then, understanding the interaction and modification of such proteins are crucial 
to find out the dynamics of the cell cycle. The regulatory proteins are mainly protein kinases 
and cyclins. Most of the time, kinases that derive the cell cycle are in an inactive form. A 
kinase is activated when it binds to a cyclin, and changes in the concentration of a cyclin 
partner leads to the changes in the activity of a kinase. For this requirement, such a kinase is 
called a cyclin-dependent kinase (Cdk). When the Cdks are activated via cyclins, they can 
perform a common biochemical reaction termed phosphorylation that activates or inactivates 
target proteins. This modification serves as a signal for entry to the next phases during the cell 
cycle progression. Mitosis promoting factor or M- phase-promoting factor (MPF) is also a 
regulatory protein composed of Cdk and cyclins and is activated at the end of G2. After the 
accumulated cyclin during the G2 binds to Cdk molecules, the resulting MPF triggers the 
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entrance into the M phase from the G2 phase through phosphorylating a variety of proteins 
required during the M phase. During anaphase (one of the mitosis stages), MPF initiates a 
process resulting in the degradation of its cyclin component and termination of the M phase. 
The Cdk part of MPF remains in the cell inactively until it binds to new molecules 
synthesized during the S and G2 phases of the next cell cycle (Campbell et al. 2008). 
 
Figure 2: The molecular mechanisms that help regulate the cell cycle 
(Adopted from Campbel 2008) 
1.3. Cell synchronization 
Cells growing in the culture are asynchronous with respect to phases of the cell cycle. The 
study of different stages of the cycle, the cell cycle control system and identifying the cell 
cycle regulated genes require synchronizing the cells. Cell synchronization is the process of 
bringing cells at different stages of the cell cycle to one particular stage of the cell division 
(Chou and Langan 2003). There is a number of methods for synchronizing the cell cultures by 
halting the cell cycle at a particular phase (Merrill 1998). A brief summary of these methods 
is presented in the following. 
1.3.1. Serum starvation 
To synchronize cells, a common and often-described technique is depriving cells of nutrients 
needed to proliferate, by placing them in a low concentration of serum which produces 
growth arrest. This puts the cells into quiescence phase (G0) or G0/G1 phase (shown in 
Figure 3) (Khammanit et al. 2008). For synchronizing the cells using this method, it is crucial 
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to be sure that the cells are not at confluence when the serum is eliminated.  The cells can be 
released from quiescence by resumption of growth, addition of normal serum concentrations, 
or treating with certain growth factors that induce cells to re-enter the cell cycle (Whitfield et 
al. 2006). 
1.3.2. Using chemical inhibitors to synchronize cells  
Other techniques use chemical inhibitors which arrest cells in specific points of the cell cycle. 
The inhibitor is then eliminated from the media and the cells can progress in the cell cycle 
synchronously. There are various inhibitors available to halt cells in different points of the 
cell cycle. When the purpose is to synchronize the cells and then keep them going afterwards, 
it is important to use reversible inhibitors (Whitfield et al. 2006). Treatment with drugs such 
as aphidico, thymidine and hydroxyurea halts cells in S phase by preventing G1 cells from 
entering the DNA synthesis stage. Consequently cells is G2, M and G1 phases will continue 
the cell cycle and accumulate at the G1/S border (Pedrali-Noy et al. 1980; Morgan D. O. 
2007). Alternatively treatment with nocodazole  halts cells in mitosis (M) phase (Figure 3) 
(Zieve et al. 1980). 
 
Figure 3: Identification of cell-cycle-regulated genes by synchronizing the cell cultures. 
(Adopted from Whitfield et al. 2006) 
 
1.4. Microarray technology 
Microarray technology is a high throughput technology used in molecular biology. It enables 
researchers to monitor and measure changes in the expression levels of thousands of genes in 
parallel under different biological conditions (Zvelebil and Baum 2008). Previous analysis of 
expression data has shown that the expression patterns in microarray experiments are similar 
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in the genes with similar functions (Brown et al. 2000). Large-scale genotyping, comparison 
of genomic hybridization, and gene expression profiling are the most common applications 
that use microarray technology (Dufva 2009). 
The following section is a brief overview of the main concepts involved in a microarray 
experiment. 
1.4.1.  What are microarrays? 
A microarray is a solid support (surface) on which DNA fragments are immobilized at 
specific positions called spots or probes in a predetermined arrangement. A microarray may 
consist of thousands of spots, and the DNA fragments fixed in spots are usually cellular 
mRNAs that have been converted to cDNAs by reverse transcription or a short stretch of 
oligo-nucleotides corresponding to a single gene (Stears et al. 2003, Selvaraj and Natarajan 
2011). The solid surface to which these DNA molecules are attached can be a glass, plastic or 
silicon chip, commonly known as the genome chip or the gene array. Also an Affymetrix chip 
can be used that is known as an Affy chip. Another microarray platform, such as Illumina, 
consists of a collection of technical replicates (microscopic beads), instead of the solid 
support. On Illumina arrays the oligonucleotides are attached to beads which are then printed 
on to the solid surface by different technologies such as photolithography or robot spotting 
(Barnes et al. 2005). In the common form of a microarray experiment, the mRNAs in the 
target sequence (target molecules) are labeled using fluorescent tags and mixed with the array 
so that the probe-target hybridization can be detected via emission of a fluorescent light 
(Madan Babu 2004). 
The main element in a microarray technology is hybridization between two DNA strands 
through forming hydrogen bonds between complementary nucleotide base pairs. 
Hybridization, also called base-pairing, is the process of joining one single stranded DNA 
fragment to the DNA fragment with the complementary sequence. Hybridization takes place 
between single stranded fragments of DNA, mRNA and cDNA and the result is double 
stranded fragments. In both DNA and RNA the base adenine (A) attaches to base thymine (T) 
in DNA and base uracil (U) in RNA, and base guanine (G) attaches to base cytosine (C) 
(Campbell 2008). 
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The most common application of gene expression microarray experiments is to detect the 
genes being expressed at a given time or compare gene expression under different conditions. 
To compare gene expression in two different conditions, a common method is to label two 
samples with different fluorescent dyes. For example, the cDNA from one sample is labeled 
with a red dye and that of another sample with a green dye. The two differentially labeled 
samples are then allowed to hybridize to particular probes on the array containing its 
complementary sequence. After washing away unbounded sequences, only strongly paired 
strands will remain hybridized. Then, the microarray is scanned with a florescence imager to 
detect the probes that have become fluorescently labeled. The florescence intensity emitted 
upon excitation reflects the amount of target sample binding to the probes (Madan Babu 2004; 
Zvelebil and Baum 2008). A microarray platform and the experimental steps involved are 
illustrated in Figure 4. 
 
Figure 4: (A) A typical microarray platform. (B) An overview of a microarray experiment and 
experimental steps involved to study differential expression of genes grown in two different conditions 
(a reference condition and a test condition). (From Madan Babu 2004) 
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1.5. Partial least squares 
Partial least squares (PLS) method is a multivariate regression approach that is suited for the 
analysis of highly dimensional data in bioinformatics and genomics. The PLS regression 
method has gained popularity in monitoring multivariate processes in the last decade, see, 
e.g., (Stone and Brook 1990; Frank and Friedman 1993; Garthwaite 1994). This was mostly 
because of the ability of multivariate statistical PLS regression to handle data with a large 
number of parameters and small sample sizes (Boulesteix and Strimmer 2006). It is valuable 
to apply the PLS method to analyze microarray data. Gene expression data from, since 
DNA microarray hybridization experiments have many measured variables (genes) and only a 
few observations (experiments). Some issues like noisy and missing data make it difficult to 
analyze the results of microarray experiments (Johansson et al. 2003). In the following 
section, we provide a short overview of PLS model. 
PLS is a dimension reduction method which is joined with a regression model. In the PLS 
regression method, the dataset (data matrix) X is associated to a response variable y. To 
minimize the dimensionality of a data matrix  X by using PLS, principal components are 
constructed. To acquire the principal components, the covariance between a linear 
combination of the original variables t = Xw, (X is the data matrix, w is the weight vector and 
t is the score vector)  and the y response is optimized by PLS regression. To study more about 
PL, see, e.g, (Martens and Naes 1989; Hoskuldsson 1996; Burnham et al. 1999; Boulesteix 
and Strimmer 2006). 
PLS is usually applied to construct a model which predicts a y-response from X. However, in 
this study the PLS  regression has been used based on Johansson et al.’s  modeling approach 
for identification of genes that are expressed periodically. They made a virtual response Y that 
shows cyclic behavior containing the same periodicity as the cell cycle. According to 
Johansson et al.’s:  “The response is constructed to represent cyclic behavior with the same 
periodicity as the cell cycle. Thus, the variables/genes that contribute signiﬁcantly to the 
models have expression patterns that appear to be coupled to the cell cycle (cyclically 
expressed). These genes include those that regulate cell cycling as well as those that are 
regulated by it” (Johansson et al. 2003). The following describes how the PLS model is being 
applied to identify genes with cyclic expression profiles.  
8 
         Prioritization of Cell Cycle Regulated Genes       
 
Visual examination of the expression proﬁles of genes has illustrated that genes that are 
cyclically expressed have expression profiles that are similar to  sine curves. Moreover, it has 
been shown that sine functions model cell cycling patterns in a precise manner (Alter et al. 
2000). Since the genes are expressed in different phases of the cell cycle, there are different 
phase angles in sine curves. If it is considered that all cyclically expressed genes are 
distinguished by periodic expression data, in the form of sin(ωt + φ), with different phases, φ, 
and a constant frequency ω, then all cyclic gene expression proﬁles are modeled by applying 
two models, sin(ωt) and cos(ωt) (Johansson et al. 2003).  
To interpret the importance of the variables, the weight vector parameter of the first principal 
component, 1w , is applied and it is calculated for increasing the estimated covariance of 
1Xw and y. Genes with large w-value will vary significantly with y (Johansson et al. 2003). 
Two models are required for a y-response, 1y for the sine curve and 2y for the cosine curve. A 
cyclically expressed gene whose expression proﬁle resembles the sine curve, will score 
significantly in the ﬁrst model, and will score slightly in the second one. For identifying such 
genes from all stages in the cell cycle, we need to employ the weight vector ( 1w ) of each 
model. For doing this, the weight vector, 1w , for the two models is plotted against each other. 
Each point in the plane is the representation of a particular gene.  Distance d , is the length 
from the centre of the coordinates to the point and shows the significance of a candidate gene  
to be coupled to the cell cycle (Figure 5). Non-cyclic expression genes are located close to the 
origin, while cyclically expressed genes are lied in a greater distance from the origin 
(Johansson et al. 2003). In addition, the direction from the origin is identified by the phase 
angle of the cyclic variation and this direction is same for genes with the same temporal 
expression patterns. 
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Figure 5: Ranking and assigning cell cycle phase. Cyclic expression genes are far away from the 
center. Genes A and B are ranked according to the distances ad  and bd , respectively, and the cell 
cycle phase assignments are determined by the angles 
A
θ and 
B
θ , respectively. (From Johansson et al. 
2003) 
1.6. Support vector machine 
In this part we first present a summary about the theory of support vector machine (SVM) and 
its application. Then, we briefly introduce the mathematical foundations of two-class and one-
class SVM. 
1.6.1.  Support vector machine: Theory 
The support vector machine (SVM) is a state of the art machine learning tool for classification 
and regression. SVM was first introduced by by Boser, Guyon and Vapnik in 1992 (Boser et 
al. 1992). SVM is based on the principle of structural risk minimization (SRM) from Vapnik’s 
statistical learning theory (1982). Statistical learning theory is a method for theoretically 
analyzing the problem of function estimation from a given data collection and also a method 
for making practical algorithms to estimate multidimensional functions. SRM’s purpose is to 
find a hypothesis which has the lowest probability of error. In Vapnik’s theory (1998), the 
bounds on the error are associated with the margin of separating hyperplanes. SVM’s goal in 
their basic form is to maximize the margin of a hyper plane that separates the training data.  
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SVMs have been successfully applied in many applications ranging from text categorization, 
face detection, hand writing recognition, and information extraction to bioinformatics. 
(Cristianini and Shawe-Taylor 2000). The properties that make the SVMs system of choice 
for these applications are flexibility in choosing a similarity function, sparseness of solution 
when there are large datasets, the ability to handle large feature spaces and identifying outliers 
(Brown et al. 2000). However, SVMs suffer from slow training especially with large input 
data size and non-linear kernels. Using SVMs efficiently needs an understanding of how they 
work. The mathematical foundation of SVMs is described in detail in (Vapnik 1998; Kecman 
2001; Müller et al. 2001; Alpaydin 2004). Section 1.6.2-1.6.4 gives a brief introduction about 
the mathematical background of SVMs in the linearly separable and non-linearly separable 
cases. 
1.6.2.  Linear support vector machines 
Let us consider that the data is linearly separable meaning that there is a hyperplane that 
classifies all data points in two classes. We are given training data points ( 1,..., )dix R i l∈ =  
with corresponding labels iy  that  is either +1 or −1, representing the class to which the data 
point ix  belongs, and the goal is to construct a binary classification. Figure 6(A) shows that 
there are many possible hyperplanes which correctly separate the positives examples from the 
negative ones, but the support vector algorithm chooses the separating hyperplane which has 
the maximum margin. This linear classifier is also known as a maximum margin classifier, as 
shown in Figure 6(B). 
11 
         Prioritization of Cell Cycle Regulated Genes       
 
 
Figure 6: SVM Linearly separable case and margins: A linear classifier is determined by a vector w 
and an offset b. (Adopted from Burges 1998) 
 
The data points x  which fall on the hyperplane, meet the following equation: 
0x w b⋅ − =                  (1) 
where: 
Vector w  is normal to the hyperplane and shows the orientation of a separating hyperplane. 
 Scalar b is the offset of the hyperplane from the origin.  
/ || ||b w  is the perpendicular distance from the hyperplane to the origin. 
 || ||w  is the Euclidean norm of w. 
The goal is choosing w and b to maximize the distance between parallel hyperplanes.  
In Figure 6(B), the data points that lie closest to the separating hyperplane are called support 
vectors (shown in circles in the Figure 6(B)). The two planes 1H  and 2H on which these 
points fall can be formulated by:  
1x w b⋅ − = +   for 1H                (2) 
1x w b⋅ − = −   for 2H                (3)                       
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We suppose that all data points can be described as follows: 
1 for 1ii w b yx ⋅ + ≥ + = +               (4) 
1 for 1ii w b yx ⋅ + ≤ − = −               (5) 
These can be written as one set of inequalities: 
( . ) 1,i i iw by x ∀+ ≥                (6)  
Simple vector geometry shows that the distance or margin is equal to 1/ || ||w  and maximizing 
the margin corresponds to finding: 
min || ||w                  (7) 
subject to: 
( . ) 1,i i iw by x ∀+ ≥  
The presented optimization problem depends on || ||w . It is possible to substitute || ||w  with 
21 || ||
2
w , the use of this term makes it possible to perform quadratic programming (QP) 
optimization later on. So we need to find 
min 
21 || ||
2
w                  (8) 
subject to: 
( . ) 1,i i iw by x ∀+ ≥  
To solve the above equation, a Lagrangian formulation of the problem (Eq.8) is considered 
and there are two reasons for this consideration. The first reason is that the Lagrangian 
constraints replace the constraint in (8), which is much softer to solve. The other reason is that 
we will have only the training data in new formulation where there are dot products between 
vectors. This important feature enables generalizing the procedure in the non linear case. 
Therefore, non-negative Lagrange multipliers iα , i = 1,…, l  are used. 
Thus, the previous problem (8) is formulated as follows: 
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2
1 1
1 || ||
2
( )
l l
i i i i
i i
L w y x w bα α
= =
= − ⋅ + +∑ ∑              (9) 
We must minimize (9) with respect to w, b, and maximize it with respect to iα , for all 
constraints 0iα ≥ . This can be done by differentiating  L with respect to w and b and setting 
the derivatives to zero: 
1
0
l
i i i
i
L w
w
y xα
=
∂
= =
∂
⇒ ∑                (10) 
1
0 0
l
i i
i
L
b
yα
=
∂
= =
∂
⇒∑                (11) 
Substituting (10, 11) into (9) leads to the following formulation which is referred to as dual 
quadratic optimization problem: 
1 1 1
1
2
l l l
i i j i j i j
i i j
L y y x xα α α
= = =
= − ⋅∑ ∑∑             (12)  
subject to: 
1
0, 0,i
l
i i
i
iy αα
=
= ≥ ∀∑  
The goal is to maximize L. In the solution each iα  with condition 0iα ≥ , indicates that the 
corresponding ix  is a support vector. The support vectors fall on the hyperplane 1H  or 2H , or 
on that side of 1H  or 2H , (according to Eq.6) (Figure 6). 
Then the decision function will be expressed as: 
1
( )
l
i i i
i
x bf x y xα
=
+=∑              (13) 
1.6.3.  Linearly non-separable case 
In the linearly non-separable case, the standard maximum margin algorithm described in the 
previous section is not able to find any separating hyperplanes to split positive and negative 
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examples. Figure 7 illustrates the linearly non-separable case. This case happens because of 
the existence of noise and mislabeled examples, or because the kernel function is not 
appropriate for the training data. So more sophisticated techniques are necessary. This 
problem can be solved by using a soft margin method that is able to take some 
misclassifications of the training examples. Soft margin relaxes the margin constraints by 
pushing some data points into another side of the hyperplane without affecting the final result. 
This method include slack variables,  , which make having misclassification or noisy 
examples possible and estimate the degree of misclassification of the data xi . 
 
 
 
Figure 7: SVM linearly non-separable case and margins 
 (Adopted from Burges 1998) 
 
The new formulation including slack variables will be:  
for 1. 1 ii i yx w b x = ++ ≥ + −            (14) 
for 1. 1 + ii i yx w b x = −+ ≤ −            (15) 
0ix ≥      i∀                        (16) 
These can be written as one set of inequalities: 
( , 0,) 1i i ii iw by x x x ≥ ∀⋅ + ≥ −                    (17) 
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If the error function is linear, the optimization problem becomes: 
2
1, ,
|| ||1
2
min
n
i
iw b
L w C
x
x
=
= + ∑             (18) 
subject to: 
( , 0,) 1i i ii iw by x x x ≥ ∀⋅ + ≥ −  
The regularization parameter C > 0 is used for determining the tradeoff between the 
complexity term and training error (Burges 1998). As in the linearly separable case, this 
optimization problem can be converted to its dual problem: 
1 1 1
1max
2
l l l
i i j i j i j
i i j
L y y x x
α
α α α
= = =
= − ⋅∑ ∑∑           (19) 
subject to: 
0 i Cα≤ ≤ ,  for all iα          
1
0
l
i i
i
yα
=
=∑                 
where l is the number of support vectors. The only difference between this case and the case 
discussed before is that in this case the size of  the Lagrange multiplier is limited by C. 
Then the decision function will be expressed as: 
1
( )
l
i i i
i
x bf x y xα
=
+=∑              (20) 
This situation is summarized in Figure 7. 
1.6.4.  Nonlinear support vector machines 
There are cases where training datasets are nonlinearly separable, and decision function is not 
a linear function of the data. In 1992, B.E. Boser, I. Guyon, and V.N. Vapnik introduced a 
way to create nonlinear classifiers. For this purpose they used kernel trick to maximum 
margin hyperplanes (Boser et al. 1992) 1T. 1TBy applying kernel trick, the feature vector of all 
training samples are first transferred to high dimensional feature space. An example of the 
16 
         Prioritization of Cell Cycle Regulated Genes       
 
effect of mapping the two-dimensional nonlinear input space into a three-dimensional linear 
feature space is demonstrated in Figure 8. The linear hyperplane is searched in this new 
feature space. If the selected nonlinear mapping is appropriate enough, then a hyperplane 
separate the data in the feature space. The kernel trick just chooses an appropriate function 
corresponding to dot product of some nonlinear mapping. Some of the most commonly 
chosen kernel functions will be shown in the last part of this section. 
 
Figure 8: Mapping of SVM into higher dimension feature space  
(Adopted from Muller et al. 2001) 
The data can become visible in the training problem in the form of dot products, i jx x⋅ , Eqs. 
(19). By mapping each data point into high dimensional space through transformation Φ:  x
 
→ φ(x), the dot product becomes:  
( , ) ( ) ( )i j i jK x x x xϕ ϕ=              (21)  
The function K(x, y) is called the kernel function. A kernel function is some function that 
corresponds to an inner product in some expanded feature space.  The use of a kernel function 
allows the SVM to operate efficiently in a nonlinear high-dimensional feature space without 
being adversely affected by the dimensionality of that space. Indeed, it is possible to work 
with feature spaces of infinite dimension. 
The new formulation using kernel function K(x, y) will be: 
     ∅ 
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Find 1... lα α  to maximize 
1 1 1
( , )1
2
l l l
i i j i j i j
i i j
L Ky y x xα α α
= = =
= −∑ ∑∑            (22) 
subject to: 
1
0
l
i i
i
yα
=
=∑                 
0 ,i C iα≤ ≤ ∀                
Then the decision function will be expressed as: 
1
( , )( ) j
l
i i i
i
K x bf x y xα
=
+=∑             (23) 
Optimization techniques for finding iα ’s are the same as before. 
A number of learning machines can be constructed by applying different kernel functions. A 
kernel function must fulfill some specific conditions (Mercer conditions). These conditions 
are explained in (Spiegelhalter et al. 1994). It is important to notice that the SVM’s 
performance will be improved by selecting the suitable kernel function based on the specific 
problem. Some common kernel functions are listed in Table 1. 
Table 1: Common kernel functions 
Kernel type Formula 
Linear kernel (Identity kernel)  ( , ) TK x x x x′ ′=  
Polynomial kernel function with degree d ( , ) ( 1)T dK x x x x′ ′= +  
Radial basis kernel function with width σ  
(RBF) 2
|| ||( , ) exp( )
2
x xK x x
σ
′− −′ =  
Sigmoid kernel function with parameters β
0
 and 
β
1
 0 1( , ) tanh( )
TK x x x xβ β′ ′= +  
1.6.5. One-class support vector machine 
The SVM algorithm introduced by Vapnik is basically a two-class algorithm as there are both 
negative and positive examples. However, there are some cases that are difficult or impossible 
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to obtain examples belonging to one specific class (Manevitz and Yousef 2001). The one-
class support vector machine (OCSVM) was introduced by Schölkopf et al. (1999). They 
proposed a method of adapting the support vector classification methodology to the problem 
of one-class classification. OCSVM can be considered as a binary SVM where the first class 
contains all the training data and the origin is treated as the only member of the second class. 
Figure 9 illustrates the OCSVM classifier. We give a brief introduction to the basic concepts 
of OCSVM in this section. The description in detail can be found in (Schölkopf  et al. 2001; 
De Bie et al. 2007). 
Like the traditional (basic) SVM, the OCSVM algorithm maps input data into a high 
dimensional feature space through transformation Φ:  x→ φ(x) and via an appropriate kernel 
function '( , )k x x . 
( , ) ( ) ( )i j i jK x x x xϕ ϕ=               (24) 
In practice, the most widely used kernel function in OCSVM is the radial basis function 
(RBF) (Schölkopf and Smola 2002). OCSVM attempts to find the maximal margin 
hyperplane that best separates the mapped vectors (training data) from the origin. In the case 
that there is no such hyperplane, slack variables , , make having misclassification examples 
possible and allow for some points to be lied within the margin. 
 
Figure 9: One-class SVM. A) Separating data from the origin. B) The data are mapped onto the 
hyperplane by RBF kernel. (Adopted from Wu and Chung 2009) 
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As presented in (Schölkopf 1999), one needs to solve the following QP problem to separate 
input data from the origin: 
2
, , 1
1 1min || ||
2w
l
i
i
w
nx ρ
x ρ
n =
−+ ∑              (25) 
subject to  
( , ( , 0,)) i iiw ixϕ x xρ ≥ ∀≥ −             
where w  is a normal vector to the hyperplane and shows the orientation of a separating 
hyperplane,   is slack variable, n  is the regularization parameter used for controlling the 
tradeoff between the complexity term and training error and it varies from 0 to 1, 
|| ||w
ρ
is the 
margin (distance from the hyperplane), and n is the number of points in the training dataset. 
The solution w and ρ of Eq.25 form the following decision function: 
( ) (( . ( )) )f x sign w xϕ ρ= −             (26) 
Applying Lagrange multipliers iα  for each vector ix , the dual form of the primal OCSVM 
problem is formulated as follows:  
1 1
( , )1min
2
l l
i j i j
i j
k x x
α
α α
= =
∑∑             (27) 
subject to: 
10 ,i nn
α≤ ≤  
and 
1
1
l
i
i
α
=
=∑  
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1.7.  Multiple Kernel Learning 
The basic idea behind kernel methods is transforming the input feature space where the 
classes are linearly separable (Vapnik 1998). Classical learning algorithms are based on a 
single kernel, but in practice it is often desirable to apply multiple kernels when learning 
problems contain multiple, heterogeneous data sources. Thanks to recent progress on SVMs 
and other kernel methods, multiple kernel learning (MKL) methods have been proposed and 
successfully applied on real world datasets (Gönen and Alpaydin 2011) . MKL provides more 
flexibility  by allowing to combine different kernels (representations) each corresponding to a 
different feature set, instead of selecting one speciﬁc kernel function. 
There are several papers focusing on efﬁcient methods to solve multiple kernel learning 
(Bennett et al., 2002; Bach et al., 2004; Bi et al., 2004; Lanckriet et al., 2004). A basic 
approach to combine different kernel matrices is to consider a convex linear combinations of 
m kernels, i.e.  
1
( , ) ( , ), ,
m
i j i j
k
k kK w i jx x x xK
=
= ∀∑            (28)  
subject to: 
0kw >  
and 
1
1
m
k
kw
=
=∑   
where is the weight of the kernel k. Different kernels can be assigned different weights 
according to their importance in the linear combination. There are different ways to tune the 
kernel weights, see, e.g., (Aerts et.al 2006).  
1.8. Data integration 
Several methods have been used for integrating multiple biological data sources with kernel 
methods. Pavlidis et al. (2002) used a combination of two fixed length data sources, 
microarray gene expression data and phylogenetic profiles, to train an SVM to recognize 
functional categories of yeast genes. To learn from combination of these two data sources, 
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they applied three different methods. Their techniques differ in the stage of integration 
process and occur at three different levels. They are referred to as early, intermediate and late 
integration (Pavlidis et al. 2002). An overview of these three techniques for two datasets is 
shown in Figure 10.  Early integration or full integration occurs at data base level. This means 
that before applying any algorithm and building an SVM model the two datasets are 
integrated to make a single dataset. This scheme has the advantage of being rather easy to 
implement when the underlying data structure allows such integration. Intermediate 
integration or the partial integration approach considers datasets as separate entities and 
datasets are combined during the learning process at the kernel level without referring back to 
the data. First, a kernel matrix is created for each dataset by applying an appropriate kernel 
function and relationships between variables within a dataset are taken into account while 
relationships between different types of variables are not considered. Then, different kernel 
matrices are added via a multiple kernel learning technique (describe in Section 1.7), that is  
. The last technique is integration at the knowledge level and is referred to 
late integration or the decision integration. In this approach, models are created on each 
dataset separately (one SVM is trained on each dataset), a decision function is derived from 
each training, then their obtained discriminant scores are summed. After comparing results, 
the best accuracy was achieved by using intermediate integration of datasets (Pavlidis et al. 
2002, Schölkopf et al. 2004).  
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Figure 10: Three methods for learning from multiple datasets. In early integration, the two datasets 
are combined to make a single dataset. In intermediate integration, one kernel is computed for each 
dataset and then kernels are summed. In late integration, one SVM is trained on each dataset, and the 
obtained discriminant scores are added. (From Daemen et al. 2009) 
1.9. Gene prioritization 
The identification of genes containing a particular biological function is an ongoing research 
issue in biology. There are often long lists of candidate genes and researchers must prioritize 
the genes from most to least promising. Gene prioritization is a predictive method based on 
existing knowledge regarding the genes known to be associated to a particular disease, 
biological function or expression pattern in different conditions and raw data. Gene 
prioritization identifies and ranks the large amount of candidate genes from most to least 
promising based on their similarity with respect to genes with known biological function.  
In this dissertation gene prioritization can be defined as: Given cell cycle regulated genes 
(training set) and unlabeled candidate genes (test set), enter these data to the computational 
method and it will give a score for each of candidate genes. Higher scoring genes are 
supposed to be the genes that are most likely cell cycle regulated and least scoring genes are 
the ones that are less likely cell cycle regulated. 
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To date, several computational methods have focused on the prioritization of candidate genes. 
In the following, we describe two main categories: classification methods and novelty 
detection methods. 
1.9.1. Classification methods 
The first step in classification is training. Training instances (genes) are marked as belonging 
to one of the multiple distinct classes. In the next step, the candidate examples are assigned 
into the different classes based on their features. In binary classification, two classes are 
defined as the positive class containing genes known to be relevant to the process under 
investigation and the negative class containing genes known not to be relevant in that process. 
Some classification methods also give a score to each candidate gene that makes the method 
to be used appropriately for gene prioritization (Adie et al. 2005, López-Bigas and Ouzounis 
2004). Applying these methods, we face the challenge that it is often difficult or impossible to 
obtain examples of one class since we do not have enough knowledge to ensure about our 
assessment (Calvo et al. 2007). 
1.9.2.  Novelty detection methods 
Novelty detection methods recognize new or unknown examples on which a learning system 
has not been trained and do not have previous knowledge (Markou and Singh 2003). During 
the last decade, Novelty detection techniques have gained wide popularity and have attracted 
a great deal of attention (Aerts et al. 2006; Gardner 2006; Rossi et al. 2006;  Zhang et al. 
2006; Gaulton et al. 2007; Ma et al. 2007; Perez-Iratxeta et al. 2007). In bioinformatics, 
novelty detection is used for a learning system where it is very difficult to guarantee that a 
gene is not involved in a biological process (there is no reliable negative training set) and the 
learning system is trained by using a positive training set. This positive set is often composed 
of genes that are known to be related to a specific process or disease under investigation. This 
knowledge can also be derived from a vocabulary of terms describing gene characteristics and 
gene annotations, such as the GO consortium (Ashburner et al. 2000). In the next step, the 
rank of candidate genes is computed according to their similarities to the genes with known 
functions. For novelty detection, several strategies have been explained in the literatures, such 
as Hidden Markov model (Yeung et al. 2002), Parzen window density estimator (Yeung et al. 
2002), KNN-based approach (Guttormsson et al.1999), one-class support vector machine 
(OCSVM) (Schölkopf et al. 1999), and etc. Among them, OCSVM is the mostly used method 
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in machine learning (Chen et al. 2011). For gene prioritization, this dissertation uses the 
application of one-class support vector machine novelty detection: finds a hyperplane that 
separates the positive data (genes that are known to be cell cycle regulated) from the origin 
with the largest possible margin and consider a gene more likely to be cell cycle regulated if 
is located farther in the direction of the hyperplane. 
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2.  Problem description 
The main idea of this project is to use machine learning techniques to identify cell cycle 
regulated genes and rank the set of candidate genes; the genes that are likely to be cell cycle 
regulated should end up in the top of the ranking list whereas the genes that are not cell cycle 
regulated should be ranked in the bottom of the list. To do this, we use gene expression 
profiles that have been produced by four gene expression experiments. Different methods 
have been used to synchronize the cell cultures in these experiments. For example double 
thymidine block halts cells in S phase whereas treatment with nocodazole  halts cells in M 
phase. Then, it is known that the gene expression profiles have been measured at different 
phases of the cell cycle. It is predicted that genes with consistent expression profiles within 
the starting point of the cell cycle in all series are more likely to have cell cycle function 
compared to those with inconsistent expression profiles. A gene up regulated during S Phase, 
such as CCNE2, should therefore be up regulated at the start of a thymidine series, and down 
regulated at the start of a nocodazaole series. We are mainly interested in genes having 
consistent cyclic expression patterns across all experiments. A PLS analysis is available for 
all time series used in this thesis. As mentioned before, the PLS model can take a given time 
series dataset from the microarray hybridization experiment and identify whether the genes’ 
expression profiles show cyclic behavior with the same periodicity as the cell cycle within the 
synchronized cells. According to PLS analysis, some genes are identified as having 
significant cyclic patterns in all four series but some are found to be significant in only 2 or 3 
out of 4 series. 
Our main strategy is using knowledge regarding how different time series have been created, 
PLS analysis information and other genes’ attributes to derive features that lead to the 
identification of genes with consistent expression profiles across multiple synchronization 
experiments. Then, we use obtained features as input to rank the set of candidate genes with 
respect to having cell cycle function. 
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3. Materials and methods 
In this part, we describe the data sets that are used to prioritize genes, and the techniques 
employed to combine different datasets. Then, we present the strategy selected to solve the 
prioritization problem. Also the methods and feature sets that are selected to reach the 
proposed approach are explained. 
3.1. Dataset Used 
In our classification model, four different gene expression experiments (datasets) are used, 
namely JCC, BJ, TT, and NS. Each experiment has measured gene expression values at 
different time points after synchronization. These are: 
• JCC consists of HaCaT cells synchronized at S phase of the cell cycle by using 
thymidine. 
• BJ consists of Foreskin Fibroblasts synchronized at G1 phase of the cell cycle by 
using serum starvation. 
• TT consists of HeLa cells synchronized at S phase of the cell cycle by using 
thymidine. 
• NS consists of HeLa cells synchronized at M phase of the cell cycle when cells start to 
divide by using nocodazole. 
Three different microarray technologies have been used for the four different experiments. TT 
and NS (HeLa cells) are both based on the Illumina microarray platform, while JCC and BJ 
are based on two different versions of the Affymetrix microarray platform. A PLS model has 
been previously developed on each experiment. Thus, there are totally four different PLS 
models (datasets) namely PLS _JCC, PLS_BJ, PLS_TT, and PLS_NS. 
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3.2. Combine different datasets  
To train the SVM, the datasets need to be combined across common genes in an appropriate 
way. In the following, we describe how common genes were identified, and how datasets 
were integrated into a reduced matrix for training the SVM. 
As mentioned above, the datasets have been produced by applying different microarray 
technologies. Since each microarray technology uses specific probe ids, there is a set of probe 
ids from different microarray technologies corresponding to a particular gene. Probe ids are 
identical between the two HeLa series which both are based on the Illumina microarray 
platform, and differ between the Foreskin Fibroblasts and HaCaT series, which used the 
Affymetrix microarray platform. For instance, the gene named “HMMR” corresponds to 
probe id "4060064" in the Illumina and probe id "207165_at" in the Affymetrix microarray 
platform. Thus, a particular gene is represented by different symbols (probes). To integrate 
the common data among four different expression experiments and make a common matrix, 
what we need is to have a common representing symbol for each gene. Since the gene names 
are always the same, what we did is to perform the analysis at the gene level instead of the 
probe level. 
Moreover, each gene can be measured by one or multiple probes in a particular microarray 
technology. This means that for some genes there exists only one probe and for some genes 
several probes. In these cases, we chose the most significant probe according to the following 
strategy:  
First probe ids are translated to gene names in each PLS model. Second, repetitive genes are 
compared according to q-values. Q-value is the minimum false discovery rate at which the 
result may be called significant. Third, duplicates are eliminated based on the amount of q-
values, that is, in different particular models only the most significant genes are selected and 
others are removed. The most significant genes are the ones whose q-values are below 0.05. 
Another challenge we faced was the cases where one gene is measured by one microarray 
technology while not measured by other technologies, so there might be some mismatches in 
expression matrix size. To overcome this, we eliminated those genes and did not consider 
them in the expression matrix. 
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3.3. Identification of consistent expression profiles 
It is already known that different methods have been used to synchronize the cell cultures by 
halting the cell cycle at a particular phase. Serum starvation puts cells into quiescence G0/G1 
phase. Double thymidine block halts cells in S phase whereas treatment with nocodazole  halts 
cells in M phase. So each experiment has started to measure gene expression values at 
different phases after synchronization. Consequently, genes that are starting as up regulated in 
a thymidin series should probably not be up regulated at the start of a nocodazole and serum 
starvation series. A truly cell cycle regulated gene would have an expression profile that is 
consistent with each series starting point of the cell cycle. Then, genes with consistent 
expression profiles in all series are very likely to be cell cycle regulated, whereas genes with 
inconsistent expression profiles in all series are not likely to have cell cycle related function. 
To find to which part of the cell cycle the time points correspond, we used the information 
about the percentage of cells assigned to the G1, S, and G2/M phases of the cell cycle for each 
time point. These cell percentages have been estimated by measuring the DNA content of 
cells in all series (Bar-Joseph et al. 2008; Peña-Diaz et al. 2013). For instance, if the majority 
of cells are in the S phase at a specific time point, it follows that this time point is 
corresponding to S phase (Figure 11-14). 
 
 
Figure 11: Percentage of cells assigned to the G1, S, and G2/M phases of the cell cycle for different 
time points in double thymidine blocked HaCaT cells (JCC). 
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Figure 12: Percentage of cells assigned to the G1, S, and G2/M phases of the cell cycle for different 
time points in Foreskin Fibroblasts experiment synchronized by serum starvation (BJ). 
 
 
Figure 13: Percentage of cells assigned to the G1, S, and G2/M phases of the cell cycle for different 
time points in nocodazole blocked HeLa cells (NS). 
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Figure 14: Percentage of cells assigned to the G1, S, and G2/M phases of the cell cycle for different 
time points in double thymidine blocked HeLa cells (TT). 
 
An example of a gene with consistent expression profiles is described below: 
Cyclin E2 (CCNE2) is a cell cycle regulated gene whose activity plays an important role for 
the cell cycle G1/S transition. The expression of CCNE2 peaks at the G1/S phase, so it is 
expected that CCNE2 is up regulated at the end of G1 phase and start of S phase. 
We consider the expression profile of CCNE2 in four differentially synchronized 
experiments, HaCaT experiment synchronized by double thymidine block (JCC), HeLa 
experiment synchronized by double thymidine block (TT), HeLa experiment synchronized by 
nocodazole (NS) and Foreskin Fibroblasts experiment synchronized by serum starvation (BJ) 
(Figure 15a-15d respectively). In each experiment, we match the time points to corresponding 
G1, S, and G2/M cell cycle phases based on Figure 11-14. It is observed that in all four 
experiments gene CCNE2 is up regulated at the end of G1 phase and start of S phase and 
down regulated at the end of S phase and start of G2/M phase. So it is concluded that for 
some genes like CCNE2, there is high consistency between four differentially synchronized 
experiments. 
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Figure 15: Time series expression profiles of CCNE2 in four differentially synchronized experiments. 
(a) CCNE2 expression profile in HaCaT experiment synchronized by double thymidine block (JCC); 
(b) CCNE2 expression profile in Foreskin Fibroblasts experiment synchronized by serum starvation 
(BJ). (c) CCNE2 expression profile in HeLa experiment synchronized by nocodazole (NS); (d) 
CCNE2 expression profile in HeLa experiment synchronized by double thymidine block (TT). 
 
Similar to what was described for CCNE2 example, we can take the expression profiles for all 
the genes and use the time series features to determine whether the expression profile within a 
specific series is consistent with the expression profile within another series. 
3.4. Construct feature sets to make OCSVM prioritization 
In this section, three sets of features applied for training the OCSVM, and the approaches 
used to reach them are described. 
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3.4.1. The first set of features – Percentage of up regulated expression profiles 
We assumed that calculating the percentage of up regulated expression profile for each gene 
would lead to identify genes with consistent cyclic expression profiles across multiple 
experiments. We used the following strategy to distinguish the up regulated expression 
profiles. 
First, the average of all expression data in all time points was computed for all genes. The 
time points where the expression data of a particular gene is above the average were 
considered as up regulated. The time points where the expression data of the particular gene is 
below the average were considered as down regulated. To identify the cell cycle phases in 
which the genes are up regulated, we assigned the time points to their corresponding cell 
cycle phases (as discussed in Section 3.3). Then we weighted them by the number of times a 
particular cell cycle phase has occurred. As an example, in the experiment synchronized by 
nocodazole (NS), gene expression values has been measured at 12 different time points in 
which  2 time points correspond to S phase, 6 time points correspond to G2/M phase, and 4 
time points correspond to G1 phase. For the particular gene CCNE2 in the experiment 
synchronized by nocodazole (NS), first, we computed the average of expression data (av= -
0.26) then, we compared each expression data with the average. It was found that CCNE2 is 
up regulated in 2 out of 2 S phases, 2 out of 4 G1 phases and 2 out of 6 G2/M phases (refer to 
Figure 13, Figure 15c and Table 2). 
 
Table 2: An overview of identifying the cell cycle phases in which the gene CCNE2 is up regulated in 
HeLa experiment synchronized by nocodazole (NS). 
Time (h) 0 0.5 1 2 3 6 9 12 15 18 21 24 
Cell cycle 
phase 
G2/
M 
G2/
M 
G2/
M 
G2/
M G1 G1 G1 G1 S S 
G2/
M 
G2/
M 
Expression 
data -1.70 -1.95 -1.52 -1.2 -0.88 -0.79 0.51 0.90 1.36 0.92 0.85 0.28 
Compare to 
av= -0.26 < < < < < < > > > > > > 
Up/Down 
(U/D) D D D D D D U U U U U U 
 
 
 
Table 3: Percentage of up regulated expression profiles for the gene CCNE2 in HeLa experiment 
synchronized by nocodazole (NS). 
33 
         Prioritization of Cell Cycle Regulated Genes       
 
Cell cycle phase S G1 G2/M 
%  of up regulated 
expression profile 
100 50 33.3 
 
 
After computing the percentages of up regulated expression profiles for all genes, each gene is 
represented as a vector with 3 property values (features) in each dataset. Since there are 4 
datasets, we ended up with a matrix in which each vector contains 12 property values (3 
properties for each dataset). Briefly, as a training set, we have a matrix with genes along the 
rows and cell cycle phases along the columns, and there is a percentage of up regulation 
corresponding to each row and column (Figure 16). 
 
 
Figure 16: Illustration of the matrix created for the first set of features. 
3.4.2. The second set of features – Assigning cell cycle phases 
The following strategy was used to assign the cell cycle phases to each gene in each 
experiment. As it is shown in Figure 17(a), the location of each gene and each sample time 
point can be found in the PLS model first and second principle components. First, the 
arctangent of the gene’s first and second principle component in the PLS model was 
computed to assign a phase angle to each gene. Second, we computed the location of the 
samples’ time points within the PLS model by computing the arctangent of the sample’s first 
and second principle components. Then, we used the information about the percentage of 
cells assigned to the G1, S, and G2/M phases of the cell cycle for each time point to find to 
which part of the cell cycle the specific time point correspond (as discussed in Section 3.3), 
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and used the cell cycle phase assignment for time points. After getting the angles of samples 
in G1, G2 and S phases of the cell cycle, we manually subdivided the plot to cell cycle 
phases. For example, if the majority of samples in a region belong to a specific phase, that 
specific phase was considered for that region. Finally, we compared each gene’s phase angle 
to the S, G2, and G1 regions of samples, and assigned the closest cell cycle phase to each 
gene.  
 
 
Figure 17: The loadings (a) and scores (b) plots for PLS model of the gene expression profiles from 
double thymidine blocked HaCaT cells (JCC). (a) Points show genes and their location within the PLS 
model’s first and second components (PC1 and PC2). Colors show the cell cycle phase where the gene 
is predominantly expressed. (b) Points show the location of the samples time points within the PLS 
model’s first and second components. 
 
After assigning the cell cycle phase to each gene in all experiments, each gene is represented 
as a vector with 3 features in each dataset. Since there are 4 datasets, we ended up with a 
matrix in which each gene contains 12 property values (3 properties for each dataset). (Figure 
18). 
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Figure 18: Illustration of the matrix created for the second set of features. 
3.4.3. The third set of features – Gene expression in different tissue type 
We added an additional feature, which does not depend on the characteristics of the time 
series expression profiles. This feature shows whether the genes are significantly up regulated 
or down regulated under different experimental conditions (tissue types). We specifically 
focused on 3 conditions namely brain, muscle and cell line. The reason for this selection lies 
behind the fact that the brain is a fairly stable tissue and once the brain cells are fully formed, 
they do not undergo cell division (Herrup and Yang 2007); also, the muscle is to some extent 
a stable tissue (Partridge 2002), therefore it is expected that genes involved in regulating the 
cell cycle would be down regulated in the brain and muscle. In contrast, the cell lines 
basically are proliferating continuously in culture (Browne and Al-Rubeai 2009), and we 
expect that genes that are involved in regulating the cell cycle would be up regulated in the 
cell lines. 
 To determine how the genes are expressed under three different conditions, we used the 
ArrayExpress repository (accession number: E-MTAB-62) (Kapushesky et al. 2010). To 
compare the significance of the differential expression, a t-statistic value was computed for 
each gene per condition. The t-statistic is a value, which is created by the statistical tests, and 
it is used to identify if a gene is differentially expressed in a given condition. A positive value 
indicates that the gene is over expressed, while a negative value shows that the gene is under 
expressed compared to the average expression of that gene over all conditions. 
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Finally, we ended up with a matrix in which genes are along the rows and the 3 different 
conditions (brain, muscle and cell line) are along the columns, and there is a t-statistic value 
corresponding to each row and column (Figure 19). 
 
Figure 19: Illustration of the matrix created for the third set of features. 
3.5. Model building for prioritization of cell cycle regulated genes 
We deﬁned the cell cycle regulated gene prioritization problem as a novelty detection problem 
and formulated it in machine learning terms. We used 4 datasets described in Section 3.1. For 
the positive training set, we selected the genes identified by PLS analysis to have significant 
cyclic expression patterns across all four datasets, and have known cell cycle function. For the 
unlabeled set, genes that are significant in only 2 out of 4 datasets and have unknown cell 
cycle function were selected. To find whether genes are cell cycle regulated, the term “Cell 
Cycle” was searched in the gene ontology (GO) annotations of the genes by using library 
“GO.db”. This library is available as an R package from the Bioconductor project: 
http://bioconductor.org. 
To construct the positive training set and the unlabeled set that is supposed to be ranked, the 
following steps were applied. 
1. Combine expression profile datasets of common genes derived from four experiments 
on which PLS models have been developed (JCC, BJ, NS, and TT). 
2. Extract genes that are significant in all 4 datasets (PLS models) and have known cell 
cycle functions and consider them as the positive training set. 
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3. Extract genes that are significant in 2 out of 4 datasets and have unknown cell cycle 
functions and consider them as the unlabeled set to be ranked. 
4. Compute percentage of up regulated expression profiles for extracted genes in step 2 
and 3, and consider them as the first set of features. 
5. Compute cell cycle phases for extracted genes in step 2 and 3, and consider them as 
the third set of features. 
6. Extract t-statistic values in the 3 different conditions, brain, muscle and cell line, for 
extracted genes in step 2 and 3, and consider them as the third set of features. 
 
Since datasets containing first, second and third feature sets have to be of the same length to 
be integrated, in the cases where no t-statistic value was found for genes in one dataset, those 
genes were removed from another datasets as well.  
After creating datasets, a kernel based method was applied to solve the problem of prioritizing 
cell cycle regulated genes. For this purpose, after feature selection, all data sources were 
transformed into kernels using an RBF kernel function. We set RBF kernel width parameter   
(σ ) to the average distance of a data point to its nearest neighbor in the union of the training 
and the test set (De Bie et al. 2007). Then, for performing novelty detection, an OCSVM 
algorithm (regularization parameter 0.1n = ), for which only the positive training genes are 
trained, was used. To perform OCSVM, we used LIBSVM implementation which is an open 
source software package for SVMs (Chang and Lin 2001). 
 For training, the approach proposed in this dissertation finds a hyperplane that separates the 
positive data from the origin. Since we used three different sets of features, there is one 
dataset per feature set. To integrate the datasets, three integration techniques, early, 
intermediate and late integration, were applied. To combine the kernels in the intermediate 
integration, I used the approach of uniformly weighted kernels in which first the kernels are 
weighted equally, and then they are summed ( 1 2
1
2
K K K= + ). 
To compare the performance of different features, we plotted a receiver operating 
characteristic (ROC) curve. An ROC curve is a two dimensional graph in which false positive 
rate (FPR) is drawn on the X-axis and true positive rate (TPR) is shown on the Y-axis. TPR, 
also known as sensitivity (SN), is the proportion of true positives (TPs), which are correctly 
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determined as positive. FPR is the fraction of false positives (FPs) out of the negatives and 
equals to one minus the specificity (SP). The area under the curve (AUC), which varies 
between 0.0 and 1.0, is a performance measure to evaluate the Roc curves. AUC measures the 
probability that a predictive model will rank a randomly selected positive sample higher than 
a randomly selected negative one. The AUC equals to 1.0 indicates a perfect prediction and 
the AUC equals to 0.5 reveals a random prediction. 
To estimate the performance of the used kernel functions, we employed a LOOCV strategy in 
which a single cell cycle regulated gene was reserved as the validation data. For each LOOCV 
iteration, one of the training genes (known cell cycle regulated genes) was singled out while 
the remaining training genes were used for the training. The singled out gene and randomly 
selected unlabeled genes were put together to make the candidate set of a fixed size. Then, the 
genes were scored and a ranking number was assigned to each of the candidate genes and the 
singled out gene. For scoring, the distance between the hyperplane and the projection of the 
candidate gene profile along the direction of the hyperplane was used. If the algorithm 
performs perfectly, it is expected that the singled out gene is ranked among the ﬁrst ones 
because there is already a known indication that it is a cell cycle regulated gene. This 
procedure was repeated so that every known cell cycle regulated gene in the training set was, 
in turn, singled out. Our schematic LOOCV process is shown in Figure 20. In the next step, 
our cross validation process and those rankings were followed by an ROC analysis. The area 
under ROC curve (AUC) was used as an indicator for the prioritization performance.  
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Figure 20: An overview of the LOOCV procedure. A repetition of prioritization runs is performed in 
the validation. In each validation run, one gene from the set of training genes (red boxes) is singled-
out and combined to candidate genes (gray boxes). The remaining training genes are used for training, 
and the model determines the ranking of all the candidate genes including the singled-out gene after 
prioritization. This step is repeated so that all the training genes are, in turn, singled-out. In the next 
step, these rankings are used to create a ROC curve. Considering a threshold on the matrix (green line) 
makes it possible to deﬁne a binary classiﬁer, the associated sensitivity and speciﬁcity, and therefore 
to draw a point in the ROC space. Changing the threshold along the matrix provides us to determine a 
complete ROC curve and it’s AUC. 
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4. Results and discussion: 
By selecting the genes that are common and significant in all 4 datasets, we ended up with 
103 genes among which 66 genes are known as cell cycle regulated (as determined by GO). 
These 66 genes were considered as the positive training set for OCSVM.  
For selecting candidate sets to be ranked (unlabeled sets), we used genes that have no known 
cell cycle function (as determined by GO), and are common in all the 4 experiments, however 
significant only in 2 out of 4 datasets. We mainly focused on two candidate sets as follows: 
Candidate set I consists of genes that are only significant in datasets NS and TT (230 genes). 
Candidate set II consists of genes that are only significant in datasets JCC and BJ (192 genes). 
 
 
Figure 21: Venn diagram showing the overlap in significant genes between four datasets. 
 
First, we considered significant genes in datasets NS and TT. This data set consists of 296 
genes out of which, 66 genes made the positive training set and 230 genes made the unlabeled 
set (candidate set II). The following results were achieved by employing RBF-OCSVM 
through LOOCV. 
- AUC of 0.89 for the first set of attributes, percentage of up regulated expression 
profiles.  
- AUC of 0.51 for the second set of attributes, cell cycle phases. 
- AUC of 0.83 for the third set of attributes, gene expression in different tissue types. 
   230 
192 
103 
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According to AUC values, the performance of the proposed approach was significant 
considering the first and third feature sets, while OCSVM behaved randomly applying the 
second feature set, and failed to prioritize genes. Plots of the above results in the ROC space 
are illustrated in Figure 22. In the next step, the first and third feature sets leading to a high 
performance were combined through three different integration methods, early, intermediate 
and late integration. We achieved AUC of 0.83 by applying early integration, and AUC of 
0.92 by applying intermediate and late integration. Comparing the results indicates that both 
the intermediate and late integration outperform early integration (Figure 23). 
The list of genes in candidate set I and their assigned ranks are shown in Table C.1 in 
Appendix C. 
 
 
Figure 22: ROC graphs for the three feature sets used for significant genes in datasets NS and TT. 
ROC curve for the first feature set, percentage of up regulated expression profiles, in blue, shows an 
AUC of 0.89. ROC curve for the second feature set, cell cycle phases, in orange, results in an AUC of 
0.51. ROC curve for the third feature set, gene expression in different tissue types, in pink, results in 
an AUC of 0.83. 
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Figure 23: ROC graphs for combining the first and third feature sets used for significant genes in 
datasets NS and TT. By applying the early, intermediate and late integration, AUC of 0.83, 0.92 and 
0.92 were achieved respectively. 
 
To find which set of combined datasets, JCC, BJ, NS and TT, used for the first feature set 
resulted in better performance for OCSVM, one of the four combined datasets was removed 
each time, and the performance of the OCSVM was estimated based on the combination of 
three remaining datasets. Following results were achieved: 
- Removing JCC and considering combination of three datasets of BJ, TT and NS for 
the first feature set resulted in AUC of 0.88. 
- Removing BJ and considering combination of three datasets of JCC, TT and NS for 
the first feature set resulted in AUC of 0.84. 
- Removing NS and considering combination of three datasets of BJ, JCC and TT for 
the first feature set resulted in AUC of 0.89. 
- Removing TT and considering combination of three datasets of BJ, JCC and NS for 
the first feature set resulted in AUC of 0.89. 
Then, we combined this feature set with the third feature set (AUC=0.83) through 
intermediate integration. Based on the results (Fig 24), it was found that OCSVM 
43 
         Prioritization of Cell Cycle Regulated Genes       
 
demonstrates a high performance considering 3 datasets instead of 4 datasets for the first 
feature set, and integration of first and third feature sets. 
 
 
 
Figure 24: ROC graphs for two feature sets and their intermediate integration used for significant 
genes in datasets NS and TT by considering 3 datasets to create the first feature set. A) Considering 3 
datasets BJ, NS and TT for the first feature set results in AUC of 0.88. Combining first and third 
feature sets (AUC=0.83) results in AUC of 0.92. B) Considering 3 datasets JCC, NS and TT for the 
first feature set results in AUC of 0.84, combining first and third feature sets results in AUC of 0.9. C) 
Considering 3 datasets JCC, BJ and TT for the first feature set results in AUC of 0.89, combining first 
and third feature sets results in AUC of 0.9. D) Considering 3 datasets JCC, BJ and NS for the first 
feature set results in AUC of 0.89, combining first and third feature sets results in AUC of 0.92. 
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In the next attempt, we focused on significant genes that are common in datasets JCC and BJ. 
The performance of OCSVM was tested on the dataset consisting 258 genes, out of which 66 
genes made the positive training set and 192genes (candidate set II) made the unlabeled set. 
This time, we used the first and third feature sets leading to a high performance in the last 
experience. We obtained a global AUC of 0.88 for the first set of attributes, percentage of up 
regulated expression profiles, and AUC of 0.82 for the third set of attributes, gene expression 
in different tissue types (Figure 25). According to AUC values, OCSVM has demonstrated 
high performance by applying these feature sets.  Then, the two feature sets were combined 
through three different integration methods. By applying early, intermediate and late 
integration, AUCs of 0.82, 0.91, and 0.90 were achieved respectively. Comparing the results 
indicates that both intermediate and late integration outperform early integration (Figure 26). 
The provided ranks for genes in candidate set II is shown in Table C.2 in Appedix C. 
 
 
 
Figure 25: ROC graphs for two feature sets used for significant genes in datasets JCC and BJ. ROC 
curve for the first feature set, percentage of up regulated expression profiles, in blue, shows an AUC of 
0.88, and ROC curve for the third feature set, in pink , results in an AUC of 0.82. 
45 
         Prioritization of Cell Cycle Regulated Genes       
 
 
Figure 26: ROC graphs for combining first and third feature sets used for significant genes in datasets 
JCC and BJ. By applying early, intermediate and late integration, AUC of 0.82, 0.91 and 0.90 were 
achieved respectively. 
 
By removing the attributes of one of the four combined datasets each time, and estimating the 
performance of the OCSVM based on the combination of the remaining three ones, the 
following results were obtained for the performance of OCSVM considering first feature set: 
- AUC of 0.89 for combination of three datasets JCC, TT and NS. 
- AUC of 0.87 for combination of three datasets BJ, TT and NS. 
- AUC of 0.87 for combination of three datasets JCC, BJ and NS. 
- AUC of 0.88 for combination of three datasets JCC, BJ and TT. 
Then, the first feature set was combined with the third feature set (AUC=0.82) through 
intermediate integration. We found that considering combination of three datasets also leads 
to a high performance for OCSVM. The ROC graphs of the results are illustrated in Figure 
27. 
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Figure 27: ROC graphs for two feature sets and their intermediate integration used for significant 
genes in datasets JCC and BJ by considering 3 datasets to create the first feature set. A) Considering 3 
datasets BJ, NS and TT for the first feature set results in AUC of 0.89. Combining the first and third 
feature sets (AUC=0.82) results in AUC of 0.91. B) Considering 3 datasets JCC, NS and TT for the 
first feature set results in AUC of 0.87, combining the first and third feature sets results in AUC of 
0.91. C) Considering 3 datasets JCC, BJ and TT for the first feature set results in AUC of 0.87, 
combining the first and third feature sets results in AUC of 0.89. D) Considering 3 datasets JCC, BJ 
and NS for the first feature set results in AUC of 0.88, combining the first and third feature sets results 
in AUC of 0.9. 
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In the continue, we describe the results obtained from the comparison of the top and bottom 
ranked genes in candidate set I and candidate set II. 
To distinguish the difference between top and bottom ranked genes, first they were compared 
by considering two sets of attributes resulted to high performance for the classifier. 
We plotted the expression profiles of 5 top and 5 bottom ranked genes (Appendix A). After 
matching their time points to corresponding G1, S, and G2/M cell cycle phases (shown in 
Figure 11-14), it was found that there is a higher consistency in the expression profile of top 
scored genes in all series compared to bottom scored ones. 
To distinguish the significance of the differential expression between top and bottom ranked 
genes, we compared their t-statistic values. It was found that the top ranked genes are mostly 
over expressed (up regulated) in cell line and under expressed (down regulated) in both brain 
and muscle. While, bottom ranked genes to some extent deviate from this pattern, and most of 
them are down regulated in cell lines. Appendix B shows the t-statistic values recorded for 5 
top and 5 bottom ranked genes in 2 candidate sets for selected conditions cell line, brain and 
muscle. 
Moreover, the function of top ranked genes was checked in the literatures. Extraction of the 
functions of genes was done by using NCBI's database for gene-specific information (Maglott 
et al. 2007). It was found that some of the top ranked gened are involved in biological 
processes related to the cell cycle which is a good indication that our learning method 
prioritizes cell cycle related genes well. Then, it is predicted that top ranked candidate genes 
with no cell cycle function such as DONSON and C16orf59 are very likely to have cell cycle 
functions and it is worth studying them experimentally. The summary of biological function 
of 10 top ranked genes in candidate set I and candidate set II are listed in Table 4 and Table 5 
respectively. 
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Table 4: The biological function of top ranked genes in candidate set I. 
Gene Name Biological function 
KIF14 plays important roles in intracellular transport and cell division. 
HMMR is potentially associated with higher risk of breast cancer. 
TRIM45 the encoded protein by this gene may function as a transcriptional repressor of the mitogen-activated protein kinase pathway. 
RSBN1 its localization to the nucleus suggest a role of the RSBN1 protein in gene expression regulation. 
BARD1 plays a central role in the control of the cell cycle in response to DNA damage. 
DONSON unknown function 
ARHGAP11A is a regulatory protein. 
ASF1A the protein encoded by this gene functions together with a chromatin assembly factor during DNA replication and repair. 
C11orf17 may be involved in maintaining chromosome integrity during mitosis. 
PTTG3P The protein encoded by this gene is related to Rho-specific exchange factors and yeast cell cycle regulators. 
KIF4A may be involved in maintaining chromosome integrity during mitosis. 
 
 
Table 5: The biological function of top ranked genes in candidate set II. 
Gene Name Biological function 
HMMR is potentially associated with higher risk of breast cancer. 
KIF14 plays important roles in intracellular transport and cell division. 
TROAP involves with bystin and trophinin in a cell adhesion molecule complex. 
ARHGAP11A is a regulatory protein. 
ASF1B 
The encoded protein is the substrate of the tousled-like kinase family of cell 
cycle-regulated kinases. 
DONSON unknown function 
BARD1 plays a central role in the control of the cell cycle in response to DNA damage. 
KIF4A may be involved in maintaining chromosome integrity during mitosis. 
ECT2 
The protein encoded by this gene is related to Rho-specific exchange factors 
and yeast cell cycle regulators. 
EXO1 functions in DNA mismatch repair to excise mismatch. 
 
We also checked the function annotations that are in common among the top and bottom 
ranked genes. We selected the first 30 top and the last 30 bottom scored genes of both gene 
candidate sets, then we used the online function annotation tool provided by database for 
annotation, visualization and integrated discovery (DAVID) (Huang et al. 2009) to investigate 
the enrichment of GO terms. GO terms analysis revealed that the significant GO biological 
terms among 30 top ranked genes, directly or potentially, are related to cell cycle, while no 
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enriched GO annotation was identified for the last 30 bottom genes of the ranking list. Table 6 
and Table 7 summarize the highest enriched GO terms for 30 top ranked genes of candidate 
set I and candidate set II respectively. 
Table 6: Enriched GO terms analysis for 30 top ranked genes in candidate set I. The listed GO terms 
are the highest enriched GO terms (Benjamin value < 0.05) selected from the highest scored GO 
cluster (Enrichment score: 2.82). Count shows the number of genes involved in GO term. 
GO term Count P_value Benjamini 
DNA metabolic process 7 2.3E-5 5.5E-3 
DNA repair 5 3.6E-4 4.3E-2 
cellular response to stress 6 5.1E-4 4.0E-2 
 
 
Table 7: Enriched GO terms analysis for 30 top ranked genes in candidate set II. The listed GO terms 
are the highest enriched GO terms (Benjamin value < 0.05) selected from the highest scored GO 
cluster (Enrichment score: 2.05). 
GO term Count P_value Benjamini 
DNA repair 6 2.7E-5 9.2E-3 
DNA metabolic process 7 3.4E-5 5.8E-3 
somatic diversification of immune receptors via 
somatic mutation 3 6.0E-5 6.8E-3 
somatic hypermutation of immunoglobulin genes 3 6.0E-5 6.8E-3 
response to DNA damage stimulus 6 9.9E-5 8.5E-3 
dna repair 5 1.6E-4 5.7E-3 
DNA damage 5 2.1E-4 5.0E-3 
somatic recombination of immunoglobulin gene 
segments 3 2.5E-4 1.7E-2 
DNA recombination 4 3.4E-4 1.9E-2 
somatic diversification of immunoglobulins 3 3.8E-4 1.9E-2 
somatic diversification of immune receptors via 
germline recombination within a single locus 3 4.5E-4 1.9E-2 
somatic cell DNA recombination 3 4.5E-4 1.9E-2 
somatic diversification of immune receptors 3 5.8E-4 2.2E-2 
cellular response to stress 6 6.9E-4 2.3E-2 
immunoglobulin production 3 7.1E-4 2.2E-2 
production of molecular mediator of immune 
response 3 7.6E-4 2.2E-2 
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5. Conclusion and future work 
The research problem we tackled in this thesis was prioritization of a list of genes with respect 
to being involved in the cell cycle related process. To do this, we used gene expression 
profiles produced by several gene expression experiments. It is already known that the gene 
expression profiles have been synchronized at different phases of the cell cycle. We were 
primarily interested in finding genes with consistent expression profiles within the starting 
point of the cell cycle in all series.  
To solve the prioritization problem, a novelty detection approach was used by employing an 
OCSVM algorithm. All data were transformed into kernels applying the RBF kernel function. 
The candidate sets were scored according to their similarity to the genes with known cell 
cycle function and the rank of the all candidate genes was recorded. To estimate the 
performance of the used kernel functions, we employed a LOOCV strategy. Three sets of 
features were derived based on information regarding how experiments have been performed 
as well as characteristics of genes. It was found that the performance of the proposed learning 
approach is significant by applying two sets of features. Then, the feature sets resulting high 
performance were combined through data integration methods and higher performance was 
achieved by applying the intermediate and late integration. Comparing the expression profiles 
of top ranked genes with bottom ranked ones, it was found that there is more consistency in 
expression profile of top scored genes. Finally, we checked the function of the top ranked 
genes and it was found that, some of them with known biological function are involved in 
biological processes related to cell cycle, which is a good indication that our learning method 
prioritizes cell cycle related genes well. Then, we can conclude that top ranked genes with 
unknown biological functions are very likely to have some functions related to cell cycle and 
it is worth studying them experimentally. 
The future work for this study would be to test the performance of our learning method by 
using additional attributes which could be derived from existing information about expression 
profiles and considering other biological characteristics of genes. In addition, other methods 
can be used to compute the attribute sets suggested and applied in this project. For example, 
one can use more accurate approach to assign the cell cycle phases to genes. We also applied 
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combination of three datasets rather than four, to test the first suggested feature set, percenge 
of upregulated expression profiles. OCSVM demonstrates a high performance for 3 combined 
datasets. However, analysis such as comparing the expresion profiles and biological functions 
of the top ranked genes with bottom ranked ones to verify the results, when 3 datasets are 
applied, is still open for further research. In this work, we prioritized two candidate sets (two 
subgroups of the Venn diagram in Figure 21), the candidate genes in other subgroups are 
suggested to be ranked in the future research. 
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Appendix A. Expression profiles for selected genes 
 
 
 
 
Figure A.1: Expression profile of selected top ranked genes in candidate set I and candidate set II. 
The selected genes are common in both candidate sets and are among the first 10 top ranked genes. 
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Figure A.2: Expression profiles of 5 bottom ranked genes in candidate set I. 
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Figure A.3: Expression profiles of 5 bottom ranked genes in candidate set II. 
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Appendix B. T-statistic values recorded for selected genes in three conditions, cell line, 
brain, and muscle. 
 
Table B.1: T-statistic values of selected top ranked genes in candidate set I and candidate set II. The 
selected genes are common in both candidate sets and are among the first 10 top ranked genes. 
Gene names T-statistic value cell line 
T-statistic value 
brain 
T-statistic value 
muscle 
HMMR 40 -21 -14 
KIF14 49 -22 -17 
ARHGAP11A 46 -18 -15 
BARD1 24 -19 -11 
DONSON 30 -15 -13 
 
Table B.2: T-statistic values of 5 bottom ranked genes in candidate set I. 
Gene names T-statistic value cell line 
T-statistic value 
brain 
T-statistic value 
muscle 
DNAJC12 -3.1 28 -4.2 
FADS1 12 8.7 -13 
COX10 9.2 -20 49 
TRIO 4.7 -5.5 3.1 
ZMAT3 -37 46 -15 
 
Table B.3: T-statistic values of 5 bottom ranked genes in candidate set II. 
Gene names T-statistic value cell line 
T-statistic value 
brain 
T-statistic value 
muscle 
SC4MOL 9.8 9.8 -24 
NFIL3 -14 -14 3.8 
DUSP10 -18 -5.5 3.1 
RGS4 -37 46 -15 
HEG1 -11 -14 18 
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Appendix C. List of candidate genes and their predicted ranks. 
  
 
Table C.1: The 230 candidate genes (candidate set I) and obtained ranks through gene prioritization. 
Ranks Genes Name Ranks Genes Name Ranks Genes Name 
1 KIF14 46 BRD8 91 RAB23 
2 HMMR 47 CDCA4 92 POLR1E 
3 TRIM45 48 S100PBP 93 RAB30 
4 RSBN1 49 RPP40 94 TIMM10 
5 BARD1 50 PRR11 95 HARS2 
6 DONSON 51 ZNF165 96 C2orf49 
7 ARHGAP11A 52 DHX40 97 HOOK1 
8 ASF1A 53 H1FX 98 SERPINH1 
9 C11orf17 54 HMGB3 99 ACYP1 
10 PTTG3P 55 PASK 100 NGFRAP1 
11 WDR76 56 CASZ1 101 PTEN 
12 KIF4A 57 MRPS12 102 MAPKAP1 
13 EXO1 58 IMPDH2 103 UPF3B 
14 MELK 59 IFIT1 104 TRIM45 
15 FAM158A 60 ABCC2 105 C10orf2 
16 C16orf59 61 FAM111A 106 AP1S2 
17 TOPBP1 62 ICMT 107 HKDC1 
18 PUS1 63 FERMT1 108 ZNF434 
19 ARHGAP19 64 SEPX1 109 DUSP11 
20 RNASEH1 65 SRSF6 110 PAQR4 
21 CTDSPL 66 EBAG9 111 TMEM5 
22 FAM64A 67 H1F0 112 AK4 
23 METTL1 68 PDSS1 113 C14orf147 
24 UNG 69 LBR 114 ASB9 
25 TTF2 70 PHACTR4 115 FOXD2 
26 NDRG3 71 C5orf13 116 FAM53B 
27 GRPEL1 72 RAD51AP1 117 C16orf61 
28 GAR1 73 GTPBP4 118 SRSF3 
29 SNAP29 74 VAPA 119 SRPRB 
30 MAP3K6 75 TPRA1 120 CD97 
31 NEIL3 76 NUP62CL 121 RBM14 
32 GOT1 77 ABCC5 122 GATA2 
33 MSH6 78 ADCK2 123 GPSM2 
34 NIP7 79 DDX18 124 AFAP1 
35 ATAD2 80 STRA13 125 ANKS1A 
36 DCAF7 81 IL17RB 126 GMCL1 
37 UBR7 82 HIST1H4C 127 IMPAD1 
38 FAM60A 83 DCTPP1 128 C8orf51 
39 DDX46 84 SLC25A38 129 UTP14A 
40 ATAD5 85 DCP2 130 UPF1 
41 TMEM194A 86 REEP1 131 SLC6A9 
42 RCL1 87 EBNA1BP2 132 ANXA10 
43 MXD3 88 UAP1L1 133 ECE2 
44 MRTO4 89 SNX2 134 ITFG2 
45 REEP4 90 ENO2 135 SLC5A6 
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Ranks Genes Name Ranks Genes Name Ranks Genes Name 
136 MTRR 181 PVT1 226 DNAJC12 
137 SOCS2 182 RPL29 227 FADS1 
138 MTHFD2L 183 NR4A2 228 COX10 
139 ZNF35 184 SNRPB2 229 TRIO 
140 SQLE 185 MDFIC 230 ZMAT3 
141 HNRNPA1 186 PLCXD1   
142 ZNF593 187 ARAP3   
143 BNIP3L 188 VWA5A   
144 WDR46 189 DPYSL2   
145 NHP2L1 190 PLEKHF1   
146 FOXF2 191 RPL34   
147 RBM12 192 DNAJB6   
148 ODC1 193 STAT2   
149 EEF1B2 194 EAF2   
150 CITED2 195 PDK4   
151 TRAK2 196 PALM   
152 CDR2 197 IMP4   
153 KIAA0355 198 DTNA   
154 SH3GL2 199 EBLN2   
155 QPCT 200 WIPI1   
156 KCTD9 201 PLSCR4   
157 KBTBD2 202 PTPRE   
158 APAF1 203 RGS20   
159 SMTN 204 ATP9A   
160 HTR3A 205 RAB40B   
161 NCAM2 206 TFAP2A   
162 ETV5 207 HEG1   
163 HADH 208 SPG11   
164 SFRS18 209 ZBED1   
165 IFT27 210 SRPK2   
166 IFIT2 211 DENND5B   
167 MTIF2 212 GBP2   
168 RHBDF1 213 PEX11B   
169 KRT16 214 PCDH7   
170 OPTN 215 PGM1   
171 HSPH1 216 UBE2A   
172 KIFAP3 217 SERPINE2   
173 DEXI 218 IFRD1   
174 RSBN1 219 TCEB3   
175 HMOX1 220 KIAA0913   
176 GK 221 INSIG2   
177 ACO1 222 GOLGA8B   
178 ACAD8 223 RAB26   
179 ADARB1 224 COL1A1   
180 GABARAPL1 225 WBP5   
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Table C.2: The 192 candidate genes (candidate set II) and obtained ranks through gene prioritization. 
Ranks Genes Name Ranks Genes Names Ranks Gene Names 
1 HMMR 46 UBR7 91 FJX1 
2 KIF14 47 DHX40 92 EFHC1 
3 TROAP 48 CASP6 93 DNAJA1 
4 ARHGAP11A 49 FUBP1 94 CDR2 
5 DONSON 50 AGFG1 95 TNFRSF10B 
6 ASF1B 51 MTDH 96 H2AFV 
7 BARD1 52 VPS37B 97 FOXF2 
8 KIF4A 53 HMGB2 98 RABGGTB 
9 ECT2 54 NFU1 99 UTP14A 
10 EXO1 55 MAT2A 100 NUP88 
11 ASF1A 56 GAPVD1 101 KANK2 
12 NIF3L1 57 CBR3 102 ZNHIT6 
13 RMI1 58 CLINT1 103 LARP4 
14 WDR76 59 FZD2 104 ADAMTS1 
15 QTRTD1 60 CCNJ 105 MREG 
16 HMGB3 61 HIST1H4C 106 MSL2 
17 FAM64A 62 POLR1C 107 SIX1 
18 C16orf59 63 GNL2 108 SLC38A1 
19 SAP30 64 MINA 109 SEC24A 
20 RPL39L 65 ZCCHC10 110 GPSM2 
21 UNG 66 TMEM97 111 NUFIP1 
22 GFPT2 67 RFX5 112 IBTK 
23 SHCBP1 68 EXOSC8 113 LDLR 
24 AVL9 69 APOBEC3B 114 SFPQ 
25 PVRL2 70 TMEM149 115 ANXA3 
26 PASK 71 MID1 116 TGIF1 
27 MSH6 72 SMYD3 117 ZBTB11 
28 RAD51 73 KDM5B 118 ZNF330 
29 PRR11 74 SGPL1 119 CDYL 
30 FAM60A 75 AHSA1 120 VEZF1 
31 CTPS 76 TFB2M 121 RAB7L1 
32 DKC1 77 MXD3 122 WSB1 
33 BRD8 78 MYC 123 SLC7A11 
34 CEBPG 79 GPR172A 124 MYST4 
35 MPHOSPH10 80 NOC3L 125 ARL6IP1 
36 H1FX 81 NOC3L 126 STX6 
37 WDR67 82 DDIT4 127 GRSF1 
38 SPA17 83 METTL21D 128 TCF7L2 
39 ARFGEF2 84 EIF3J 129 GRPEL1 
40 NET1 85 CCNT2 130 EMP1 
41 CLDN4 86 RPIA 131 ENTPD4 
42 UCK2 87 MAP4K4 132 ZNF12 
43 IFIT1 88 H1F0 133 OPCML 
44 EIF3A 89 FANCE 134 MKNK2 
45 EPS8 90 TRAF3 135 ACSL3 
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Ranks Genes Name Ranks Genes Name 
136 TFPI 181 PDCD4 
137 PDGFA 182 BTG1 
138 SPTLC2 183 HOMER1 
139 FKBP14 184 NPC1 
140 SLC2A6 185 OPTN 
141 SLC33A1 186 PIKFYVE 
142 C11orf95 187 ACSL1 
143 IFIT2 188 SC4MOL 
144 EAPP 189 NFIL3 
145 C1orf103 190 DUSP10 
146 PLXNA1 191 RGS4 
147 ACSL4 192 HEG1 
148 CDK19   
149 TMEM2   
150 MAP2K3   
151 GFPT2   
152 SLC7A6   
153 HNRNPA3   
154 TM4SF1   
155 EIF2AK3   
156 OSBPL2   
157 SENP6   
158 IFIT3   
159 SLC19A2   
160 SS18L1   
161 JMJD6   
162 NUAK1   
163 SACS   
164 ECM2   
165 CREB3L2   
166 PANK3   
167 BIRC3   
168 ATP2B1   
169 IRF7   
170 ANKRD27   
171 AJAP1   
172 FZD7   
173 RPL28   
174 SNX1   
175 GDPD5   
176 KDM5A   
177 PLEKHF1   
178 PLEKHF1   
179 AHI1   
180 CCL2   
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